KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 152 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $87,600,000 | -33.9% | 6,000,000 | -14.3% | 1.24% | -52.5% |
Q2 2020 | $132,580,000 | -1.4% | 7,000,000 | 0.0% | 2.62% | -42.3% |
Q1 2020 | $134,470,000 | +18.9% | 7,000,000 | +18.6% | 4.54% | +36.7% |
Q4 2019 | $113,103,000 | +94.3% | 5,900,000 | -2.5% | 3.32% | +36.8% |
Q3 2019 | $58,201,000 | +673.5% | 6,050,000 | +979.1% | 2.43% | +576.3% |
Q1 2018 | $7,524,000 | – | 560,658 | – | 0.36% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
COMMODORE CAPITAL LP | 3,561,052 | $26,245,000 | 5.86% |
Palo Alto Investors LP | 5,621,533 | $41,431,000 | 3.20% |
Iron Triangle Partners LP | 2,000,000 | $14,740,000 | 1.75% |
Altium Capital Management LP | 645,000 | $4,754,000 | 1.59% |
Birchview Capital, LP | 269,332 | $1,985,000 | 1.43% |
Rubric Capital Management LP | 3,607,443 | $26,587,000 | 0.96% |
Lombard Odier Asset Management (Switzerland) SA | 776,053 | $5,720,000 | 0.45% |
RICE HALL JAMES & ASSOCIATES, LLC | 1,344,929 | $9,912,000 | 0.40% |
Golden State Equity Partners | 41,850 | $308,000 | 0.16% |
Hennion & Walsh Asset Management, Inc. | 385,837 | $2,844,000 | 0.15% |